An interventional study of Grade II central posterior-to-anterior spinal mobilization and Grade IV central posterior-to-anterior spinal mobilization in Low Back Pain, sponsored by New York Institute of Technology. Not yet recruiting. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-19.
Sponsored by New York Institute of Technology · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Research shows 85% of the population will experience at least one episode of low back pain (LBP) in their lifetime. The annual cost to manage LBP in the U.S. can exceed 2 billion dollars. A conservative approach to LBP management can be provided by a physical therapist through interventions such as spinal mobilization. Spinal mobilizations are graded (I-IV) based upon the varying depths and impulse frequency at which they are applied to the target tissue. Functional magnetic resonance imaging (fMRI) studies have shown that spinal mobilizations (grade III, grade V) can stimulate pain suppression and provide favorable neurophysiological effects on pain modulation.
No studies to date, however, have examined the neurophysiological influence of grades II and IV on pain modulation. The purpose of this study is to investigate the change in pain suppression following spinal mobilization (i.e., grades II and IV).
A conservative approach to LBP management can be provided by a physical therapist through interventions such as spinal mobilization. Spinal mobilizations are defined as passive movements to the spinal joints at varying speeds and amplitudes to restore accessory motion and optimize joint function. Spinal mobilizations are graded (I-IV) based upon the varying depths and impulse frequency in which they are applied to the target tissue. Grades I and II are applied more superficially to the tissue just prior to the onset of tissue resistance. These grades are often used for pain modulation in individuals who report high levels of pain and may present as reactive and irritable. Grades III and IV are applied deeper into the tissue resistance and are primarily used to increase tissue extensibility and joint mobility. These grades are often used with individuals who primarily report stiffness and mobility loss with lower levels of pain.
A proposed mechanism associated with spinal mobilization is the neurophysiological influence on pain modulation through activation of descending inhibitory pathways. Functional magnetic resonance imaging (fMRI) studies have shown that spinal mobilizations (grade III, grade V) can stimulate the salience network and provide favorable neurophysiological effects on pain modulation. This is determined by measuring the change in peak blood-oxygen-level-dependent (BOLD) signal from predefined regions of interest (ROIs). These ROIs include the prefrontal cortex, precuneus, anterior/posterior insulas, thalamus, anterior/posterior cingulate cortices, somatosensory cortex, secondary somatosensory cortex, and periaqueductal gray. Computing correlations between region pairs will determine functional connectivity (FC) and show which brain regions are most active.
No studies to date have examined the neurophysiological influence of grades II or IV on the salience network stimulation and pain modulation. These grades vary greatly with respect to their frequency and depth of application but may still provide similar pain modulation outcomes. The purpose of this study is to investigate the change in salience network stimulation following spinal mobilization (i.e., grades II and IV).
2,930 studies on the registry are indexed under Low Back Pain; 580 are open to participants now.
This study's planned enrollment of 10 is below the median of 60 across 2,368 interventional studies indexed under Low Back Pain.
Browse Low Back Pain studies →New York Institute of Technology is the lead sponsor of 60 studies on the registry; 16 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
A. New York Tech students B. Age range: at least 18 years old C. Good overall health D. Mechanical low back pain ≥ 1 month *(source of pain is muscular or skeletal) E. Pain intensity of at least 4/10 or greater
Exclusion Criteria:
A. Claustrophobia B. IEDs including: pacemakers, internal defibrillators, and insulin pumps C. Medical implants or metallic foreign bodies, not limited ferrous metals D. Any previous history of lumbar surgery, nerve root involvement, stenosis (narrowing of the spinal canal), or mechanical instability E. Pregnancy F. Use of opioid medication G. LBP secondary to disease or systemic cause H. History of cardiovascular disease or high blood pressure I. History of Type I or Type II Diabetes J. History of neurodevelopmental disorders K. Prolonged * use *(e.g., prednisone, dexamethasone, hydrocortisone, etc.) L. Oswestry Low Back Disability Index (ODI) score of \<5 M. Inability to provide
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.
Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Corticosteroids (steroids)
Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.
Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
A grade II posterior-to-anterior spinal mobilization will be applied to the individual's lumbar spine for a total of five minutes.
Other: Grade II central posterior-to-anterior spinal mobilization
A grade IV posterior-to-anterior spinal mobilization will be applied to the individual's lumbar spine for a total of five minutes.
Other: Grade IV central posterior-to-anterior spinal mobilization
A grade II spinal mobilization is applied to the spinal segment in a posterior-to-anterior direction to a tissue depth before the first onset of tissue resistance.
Grade IV central posterior-to-anterior spinal mobilization will be applied to the lumbar spine for five minutes to a tissue depth of 50% of the tissue resistance.
Numeric Pain Rating Scale
This 11-point numeric scale ranges from '0' representing one pain extreme (e.g., "no pain") to '10' representing the other pain extreme (e.g., "pain as bad as you can imagine" or "worst pain imaginable").
Time frame: At both sessions of care, from enrollment to the end of treatment at week 2
No study locations are listed for this record.
Plan to share: Undecided
Start is estimated for Nov 2026; primary completion for Feb 2027, 3 months later.
Of 1,234 non-industry interventional studies with no phase under Low Back Pain, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 26. This study's planned 3 months is below that.
Counting every sponsor, half of 1,290 studies reached it within 11 months; a quarter within 5 and three quarters within 27.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
New York Institute of Technology